Physician profile
Trac T Le
NPI 1346222452
$784.51
in general payments reported to CMS, 2019-2025
13 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.41 · 2021: $11.44 · 2022: $14.80 · 2023: $144 · 2024: $191 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.25 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $191.05 | 2025 | Terlivaz, Acthar |
| Amgen INC. | $143.76 | 2024-2025 | Krystexxa |
| Vantive US Healthcare LLC | $103.74 | 2025 | Renal - Pd |
| Baxter Healthcare | $99.96 | 2023 | |
| Aurinia Pharma U.S., INC. | $74.69 | 2024 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $32.41 | 2023-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $26.24 | 2021-2022 | |
| Akebia Therapeutics INC | $24.61 | 2024 | Vafseo |
| Ani Pharmaceuticals, INC. | $24.40 | 2024 | Purified Cortrophin Gel |
| Calliditas Therapeutics US INC. | $22.66 | 2023 | Tarpeyo |
| Idorsia Pharmaceuticals US INC | $21.69 | 2025 | Tryvio |
| Vifor Pharma, INC. | $15.41 | 2020 | |
| Travere Therapeutics, INC. | $3.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trac Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.